Medical Marijuana, Inc.
Paraguay Government Grants Historic Import Permit for Medical Marijuana, Inc.'s Real Scientific Hemp Oil(TM) Into Paraguay for Treatment of Epilepsy
Real Scientific Hemp Oil(TM) (RSHO(TM)) Cannabidiol (CBD) Hemp Oil Demand Grows as Countries Including Brazil, Mexico, Puerto Rico and Paraguay Authorize Its Import From the U.S.
SAN DIEGO, CA--(Marketwired - May 31, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) is pleased to announce that its flagship product Real Scientific Hemp Oil â¢ (RSHOâ¢) has been authorized by Paraguay's government for import into the country as a prescription medication for refractory epilepsy.
Paraguay's first-ever import permit for RSHO â¢ marks the fourth country in Latin America, after Brazil , Puerto Rico , and Mexico , to approve MJNA's cannabidiol (CBD) hemp oil for indications including epilepsy, Parkinson's disease, chronic pain, and cancer.
The first shipment of RSHO â¢ into Paraguay was authorized for 15-year-old Mathias Alejandro Gonzalez, who was diagnosed with an autism spectrum disorder and suffers from Lennox-Gastaut Syndrome (LGS), a rare type of epilepsy that doesn't respond well to seizure medications.
"We are extremely proud of the wonderful news that RSHOâ¢ has been approved for import by the government of Paraguay," states Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. "In the U.S., we enjoy the ability to easily access RSHOâ¢ and many other CBD hemp oil products online. However, in other countries, we must respect their regulations and handling of cannabis-based products including hemp."
"MJNA is a 'Company of Firsts'," Titus continues. "It took many years to establish and streamline a standardized commercial system while developing the world's first CBD hemp oil pipeline. We are extremely grateful to our investors who also saw and continue to see the vision of CBD hemp oil access in the U.S. and around the world."
In February of 2015, HempMedsÂ® received authorization to export Real Scientific Hemp Oil-Xâ¢ (RSHO-Xâ¢) to individuals in Mexico with government-issued import permits. Raul and Mayela Elizalde from the Por Grace Foundation, based in Mexico, helped explain their daughter Grace's need for the cannabidiol (CBD) hemp oil product for a case similar to that of Mathias Gonzalez's family in Paraguay -- and were instrumental in the process of securing the permit. Since 2014, the government of Brazil continues to issue import permits for RSHOâ¢ , as well as subsidize payments for the product under the federal government's healthcare system -- and also waive import taxes.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visitÂ www.medicalmarijuanainc.com .
The Company is committed to consistently providing theÂ highest-quality CBD hemp oil products Â on the market. To see Medical Marijuana, Inc.'s video statement,Â click here . Shareholders are also encouraged to visit theÂ Medical Marijuana, Inc. Shop Â for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The following files are available for download:
For further information, please contact:
Public Relations contact:
Chief Executive Officer
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6505
Information om Marketwired
Følg pressemeddelelser fra Marketwired
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Marketwired
Bombardier Inc.21.11.2017 01:16 | pressemeddelelse
Bombardier Announces Pricing of its New Issuance of Senior Notes due 2024
Algeco Scotsman20.11.2017 18:41 | pressemeddelelse
Statement Regarding Withdrawal of Complaint Filed on Behalf of Senior Unsecured Noteholders
Bombardier Inc.20.11.2017 16:02 | pressemeddelelse
Bombardier Announces a Cash Tender Offer for Any and All of its 4.75% Senior Notes due 2019
Bombardier Inc.20.11.2017 15:06 | pressemeddelelse
Bombardier Announces Launch of its New Issuance of Senior Notes due 2024
Algeco Scotsman16.11.2017 21:11 | pressemeddelelse
Statement Regarding Complaint Filed on Behalf of Senior Unsecured Noteholders
Cisco15.11.2017 22:06 | pressemeddelelse
Cisco Reports First Quarter Earnings
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum